Cycloastragenol mediates activation and proliferation suppression in concanavalin A-induced mouse lymphocyte pan-activation model. (4th May 2017)
- Record Type:
- Journal Article
- Title:
- Cycloastragenol mediates activation and proliferation suppression in concanavalin A-induced mouse lymphocyte pan-activation model. (4th May 2017)
- Main Title:
- Cycloastragenol mediates activation and proliferation suppression in concanavalin A-induced mouse lymphocyte pan-activation model
- Authors:
- Sun, Chenghong
Jiang, Mingmin
Zhang, Li
Yang, Jian
Zhang, Guimin
Du, Bingyuan
Ren, Yushan
Li, Xin
Yao, Jingchun - Abstract:
- Abstract: Context: Cycloastragenol (CAG) is a molecule isolated from various species in the genus Astragalus . Although the regulatory activity of Astragalus on immune system has been investigated, the effect of CAG on activated lymphocytes is poorly understood. Objective: We aimed to biologically address the possible anti-inflammation potential of CAG on concanavalin A (Con A)-mediated mouse lymphocyte pan-activation model. Materials and methods: Mouse lymphocytes were obtained from spleens and subjected to Con A for 24 h. Herein, the cells were treated with different concentrations of CAG. Cell viability was assayed by MTT. Pretreated by CAG and stimulated by Con A, the expression of CD69 and CD25, Th1/Th2/Th17 cytokines, cell cycle, proliferation and intracellular Ca 2+ concentration ([Ca 2+ ]i ) were analyzed by flow cytometry. Results: The results declared that CAG significantly downregulated both CD69 and CD25 expressed on Con A activated CD3 + T cells' surface, as well as inhibiting proliferation of activated lymphocytes. In addition, CAG blocked the Con A-induced mitogenesis, exhibiting lymphocyte G0 /G1 -phase cell-cycle arrest with significant reduction of cells in S and G2 /M phases. Meanwhile, pretreated by CAG, a significant decline in [Ca 2+ ]i was observed. Furthermore, CAG significantly inhibited the production of Th1 cytokines IFN-γ, TNF, IL-2, Th2 cytokines IL-4, IL-6, IL-10 and Th17 cytokine IL-17 A on Con A-activated lymphocytes. Conclusion: Our resultsAbstract: Context: Cycloastragenol (CAG) is a molecule isolated from various species in the genus Astragalus . Although the regulatory activity of Astragalus on immune system has been investigated, the effect of CAG on activated lymphocytes is poorly understood. Objective: We aimed to biologically address the possible anti-inflammation potential of CAG on concanavalin A (Con A)-mediated mouse lymphocyte pan-activation model. Materials and methods: Mouse lymphocytes were obtained from spleens and subjected to Con A for 24 h. Herein, the cells were treated with different concentrations of CAG. Cell viability was assayed by MTT. Pretreated by CAG and stimulated by Con A, the expression of CD69 and CD25, Th1/Th2/Th17 cytokines, cell cycle, proliferation and intracellular Ca 2+ concentration ([Ca 2+ ]i ) were analyzed by flow cytometry. Results: The results declared that CAG significantly downregulated both CD69 and CD25 expressed on Con A activated CD3 + T cells' surface, as well as inhibiting proliferation of activated lymphocytes. In addition, CAG blocked the Con A-induced mitogenesis, exhibiting lymphocyte G0 /G1 -phase cell-cycle arrest with significant reduction of cells in S and G2 /M phases. Meanwhile, pretreated by CAG, a significant decline in [Ca 2+ ]i was observed. Furthermore, CAG significantly inhibited the production of Th1 cytokines IFN-γ, TNF, IL-2, Th2 cytokines IL-4, IL-6, IL-10 and Th17 cytokine IL-17 A on Con A-activated lymphocytes. Conclusion: Our results reinforce that CAG has important anti-inflammatory activity by inhibiting lymphocytes activation, proliferation and cytokines expression, and shows, that this effect may be related to reduction of overall intracellular Ca 2+ overload. … (more)
- Is Part Of:
- Immunopharmacology and immunotoxicology. Volume 39:Number 3(2017:Jun.)
- Journal:
- Immunopharmacology and immunotoxicology
- Issue:
- Volume 39:Number 3(2017:Jun.)
- Issue Display:
- Volume 39, Issue 3 (2017)
- Year:
- 2017
- Volume:
- 39
- Issue:
- 3
- Issue Sort Value:
- 2017-0039-0003-0000
- Page Start:
- 131
- Page End:
- 139
- Publication Date:
- 2017-05-04
- Subjects:
- Cycloastragenol -- anti-inflammation -- lymphocytes -- Ca2+ -- proliferation
Immunopharmacology -- Periodicals
Immunotoxicology -- Periodicals
Antibody-toxin conjugates -- Periodicals
Immunology -- Periodicals
615.37 - Journal URLs:
- http://informahealthcare.com/journal/ipi ↗
http://informahealthcare.com ↗ - DOI:
- 10.1080/08923973.2017.1300170 ↗
- Languages:
- English
- ISSNs:
- 0892-3973
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 4369.760200
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 181.xml